Prolylcarboxypeptidase (PRCP) as a new target for obesity treatment

B Shariat-Madar1, D Kolte2, A Verlangieri2, Z Shariat-Madar21College of Literature, Science, and the Arts, University of Michigan, Ann Arbor MI, USA; 2School of Pharmacy, Department of Pharmacology, University of Mississippi, University, MS, USAAbstract: Recently, we serendipitously discovered that...

Full description

Bibliographic Details
Main Authors: Shariat-Madar Z, Shariat-Madar B, Kolte D, Verlangieri AJ
Format: Article
Language:English
Published: Dove Medical Press 2010-04-01
Series:Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy
Subjects:
Online Access:https://www.dovepress.com/prolylcarboxypeptidase-prcp-as-a-new-target-for-obesity-treatment-peer-reviewed-article-DMSO